Welcome to ClarityMD!

Product was successfully added to your shopping cart.

Clinically Proven Results - Felipe Jiminez


CLINICALLY PROVEN

ClarityMD® has been clinically proven to:

  • Reduce the amount of oil present in pores. This causes fewer overall acne outbreaks and improves the appearance of skin. Lower oil production means fewer pimples and less redness and irritation.
  • Reduce the inflammation that accompanies outbreaks. One thing that leads to the red, mottled appearance of acne outbreaks is inflammation. Skin reacts to the bacteria and oil in pimples and attempts to control this "infection" by routing blood to the area. This results in increased skin temperature and redness. ClarityMD soothes and cools the skin to give a smoother appearance and to comfort inflammation.
  • Reduce the number and size of pimples. Essentially, pimples are spots where pores are clogged and have become engorged and inflamed. The body makes white blood cells to fight the bacteria present in the clogged pores, leading to the appearance of papules and pustules. ClarityMD reduces the amount of bacteria in the clogged pores, allowing the body's natural healing process to take over.
  • Reduces surface scarring. By allowing the body to naturally heal pimples, scarring is less prevalent. The scarring that is often seen with acne can be due to the pimples themselves or to unsuccessful attempts to treat them.
 

Clinical Study

Complete Clinical Study was published at the Journal of Drugs Dermatology by Ashish C. Bhatia MD, and Felipe Jimenez PhD, Rapid Treatment of Mild Acne With a Novel Skin Care System Containing 1% Salicylic Acid, 10% Bufered Glycolic Acid and Botanical Ingredients, J Drugs Dermatol. 2014;13(6). To download, click Complete Clinical Study link below. (To view the PDF file, you will need Adobe Acrobat Reader installed on your PC. If necessary, you can install Acrobat Reader at https://get.adobe.com/reader/.

Complete Clinical Study - Download PDF

The safety and efficacy of twice-daily use of the ClarityMD™ Acne Solution was assessed in a 6-week open-label clinical study in 25 male and female volunteers, ages 12-35, having mild-to-moderate acne vulgaris. Efficacy was measured as a function of mean (average) change from baseline in number of inflammatory (red bumps, papules and pustules) and non-inflammatory (whiteheads, black heads) acne lesions at weeks 1, 2, 4 and 6 as shown in the table below.


* Specific results are not guaranteed and individual results may vary.

Connect with us Instagram You Tube